市場調查報告書
商品編碼
1298657
蛋白質工程市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測Protein Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球蛋白質工程市場規模達到30億美元。展望未來,IMARC Group預計到2028年,市場規模將達到57億美元,在2023-2028年期間表現出11.2%的成長率(CAGR)。
蛋白質工程是指開發或改變蛋白質序列以達到預期結果的過程。它涉及到新蛋白質的合成或現有結構或序列的修正,並採用重組脫氧核糖核酸(DNA)技術來改變氨基酸序列以獲得新的和增強的功能。它被廣泛用於生產大量的酶或蛋白質,以便在工業環境中使用。近年來,研究人員已經成功地設計了一系列適合醫藥、研究、工業、健康和生物技術應用的蛋白質,這使它們在全球的需求不斷增加。
對合成生物學的投資增加,以及對基於蛋白質的藥物開發的關注度提高,是推動市場成長的主要因素。此外,由於非蛋白質藥物具有積極的臨床效果,人們已經開始向蛋白質治療藥物轉變。這一點,再加上蛋白質缺乏的疾病的廣泛流行,正在增加對蛋白質工程的需求。此外,各國政府採取的一些有利計劃,如增加對蛋白質工程領域的研究和開發(R&D)活動的資助,正在推動市場成長。除此之外,重組單克隆抗體(mAbs)的出現和擴大使用單克隆抗體來治療各種疾病,如癌症和自身免疫性疾病,正在加速產品的採用率。此外,正在進行的在農業化學工業中應用蛋白質工程的研究,以產生具有增強功能的酶來增加作物產量或促進生物燃料的生產,正在催化市場成長。其他因素,包括對個性化藥物的需求升級、對生物學名藥和生物製劑的需求成長、醫療保健基礎設施的改善、技術進步和產品創新,也在為市場創造積極的前景。
The global protein engineering market size reached US$ 3.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.2% during 2023-2028.
Protein engineering refers to the process of developing or changing a protein sequence to achieve the desired result. It involves the synthesis of new proteins or amendments in the existing structure or sequence and employs recombinant deoxyribonucleic acid (DNA) technology to alter amino acid sequences for novel and enhanced functions. It is widely utilized for the production of enzymes or proteins in large quantities for use in industrial settings. In recent years, researchers have successfully engineered a wide range of proteins tailored to medicine, research, industry, health, and biotechnology applications, which is escalating their demand across the globe.
The rising investments in synthetic biology and the improving focus toward protein-based drug development represent the primary factors driving the market growth. Additionally, there has been a significant shift toward protein therapeutics from non-protein drugs due to their associated positive clinical outcomes. This, in confluence with the widespread prevalence of protein-deficient diseases, is increasing the demand for protein engineering. Furthermore, several favorable initiatives undertaken by the government of various countries, such as increased funding for research and development (R&D) activities in the field of protein engineering, are propelling the market growth. Besides this, the advent of recombinant monoclonal antibodies (mAbs) and the increasing usage of monoclonal antibodies to treat various diseases, such as cancer and autoimmune diseases, are accelerating product adoption rates. Moreover, the ongoing research for applications of protein engineering in the agrochemical industry to generate enzymes with enhanced function to increase the crop yield or facilitate biofuel production is catalyzing the market growth. Other factors, including the escalating demand for personalized medicines, growing need for biosimilars and biologics, improving healthcare infrastructure, technological advancements, and product innovations, are also creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein engineering market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product & services, protein type, technology and end user.
Instruments
Reagents
Services and Software
Insulin
Monoclonal Antibodies
Coagulation Factors
Vaccines
Growth Factors
Others
Irrational Protein Design
Rational Protein Design
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Contract Research Organizations
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abzena Ltd., Agilent Technologies Inc., Amgen Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Codexis Inc., Danaher Corporation, Eli Lilly and Company, General Electric Company, Merck KGaA, Novo Nordisk A/S, PerkinElmer Inc., Thermo Fisher Scientific Inc. and Waters Corporation.
Key Questions Answered in This Report
1. What was the size of the global protein engineering market in 2022?
2. What is the expected growth rate of the global protein engineering market during 2023-2028?
3. What are the key factors driving the global protein engineering market?
4. What has been the impact of COVID-19 on the global protein engineering market?
5. What is the breakup of the global protein engineering market based on the product and services?
6. What is the breakup of the global protein engineering market based on the protein type?
7. What is the breakup of the global protein engineering market based on the technology?
8. What is the breakup of the global protein engineering market based on the end user?
9. What are the key regions in the global protein engineering market?
10. Who are the key players/companies in the global protein engineering market?